[1] Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D. M., Forman D., and Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5):E359–86, 2015.
[2] Volksgezondheid. Volksgezondheid info. https://www.volksgezondheidenzorg.info.
[3] American Cancer Society. Cancer facts and figures 2015. http://oralcancerfoundation.org/ wp-content/uploads/2016/03/Us_Cancer_Facts.pdf.
[4] Kushihashi T., Munechika H., Ri K., Kubota H., Ukisu R., Satoh S., Motoya H., Kurashita Y., Soejima K., and Kadokura M. Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology, 193(3):789–793, 1994.
[5] Zwirewich C. V., Miller R. R., and Müller N. Multicentric adenocarcinoma of the lung: CT- pathologic correlation. Radiology, 176(1):185–190, 1990.
[6] Henschke C. I., Yankelevitz D. F., Mirtcheva R., McGuinness G., McCauley D., and Miettinen O. S. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. American
Journal of Roentgenology, 178(5):1053–1057, 2002.
[7] Hansell D. M., Bankier A. A., MacMahon H., McLoud T. C., Muller N. L., and Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 246(3):697–722, 2008.
[8] Godoy M. C., Truong M. T., Sabloff B., and Naidich D. P. Subsolid pulmonary nodule management and lung adenocarcinoma classification: state of the art and future trends. Seminars in
Roentgenology, 48(4):295–307, 2013.
[9] Godoy M. C. and Naidich D. P. Subsolid pulmonary nodules and the spectrum of peripheral adeno- carcinomas of the lung: recommended interim guidelines for assessment and management.
Radiology, 253(3):606–622, 2009.
[10] Team N. L. S. T. R., Aberle D., Adams A., Berg C., Black W., Clapp J., Fagerstrom R., Gareen I., Gatsonis C., Marcus P., and Sicks J. Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 2011(365):395–409, 2011.
[11] Zhao Y. R., Xie X., de Koning H. J., Mali W. P., Vliegenthart R., and Oudkerk M. NELSON lung cancer screening study. Cancer Imaging, 11(1A):S79, 2011.
[12] Wille M. M., Dirksen A., Ashraf H., Saghir Z., Bach K. S., Brodersen J., Clementsen P. F., Hansen H., Larsen K. R., Mortensen J., et al. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. American Journal of Respiratory and Critical Care Medicine, 193(5):542– 551, 2016.
[13] Field J. K., Duffy S. W., Baldwin D. R., Brain K. E., Devaraj A., Eisen T., Green B. A., Holemans J. A., Kavanagh T., Kerr K. M., et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health
Technology Assessment, 20(40):1, 2016.
[14] Paci E., Puliti D., Pegna A. L., Carrozzi L., Picozzi G., Falaschi F., Pistelli F., Aquilini F., Ocello C., Zappa M., et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax, 72(9):825–831, 2017.
[15] Infante M., Cavuto S., Lutman F. R., Brambilla G., Chiesa G., Ceresoli G., Passera E., Angeli E., Chiarenza M., Aranzulla G., et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. American Journal of Respiratory
and Critical Care Medicine, 180(5):445–453, 2009.
[16] van Klaveren R. J., Oudkerk M., Prokop M., Scholten E. T., Nackaerts K., Vernhout R., van Iersel C. A., van den Bergh K. A., van’t Westeinde S., van der Aalst C., et al. Management of lung nodules detected by volume CT scanning. New England Journal of Medicine, 361(23):2221–2229, 2009. [17] McWilliams A., Tammemagi M. C., Mayo J. R., Roberts H., Liu G., Soghrati K., Yasufuku K., Martel S.,
Laberge F., Gingras M., et al. Probability of cancer in pulmonary nodules detected on first screening
[18] Callister M., Baldwin D., Akram A., Barnard S., Cane P., Draffan J., Franks K., Gleeson F., Graham R., Malhotra P., et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax, 70(Suppl 2):ii1–ii54, 2015.
[19] Raad R. A., Suh J., Harari S., Naidich D. P., Shiau M., and Ko J. P. Nodule characterization. Radiologic
Clinics, 52(1):47–67, 2014.
[20] Lee K. H., Goo J. M., Park S. J., Wi J. Y., Chung D. H., Go H., Park H. S., Park C. M., and Lee S. M. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. Journal of
Thoracic Oncology, 9(1):74–82, 2014.
[21] Ko J. P., Suh J., Ibidapo O., Escalon J. G., Li J., Pass H., Naidich D. P., Crawford B., Tsai E. B., Koo C. W., et al. Lung adenocarcinoma: correlation of quantitative CT findings with pathologic findings.
Radiology, 280(3):931–939, 2016.
[22] Aoki T., Tomoda Y., Watanabe H., Nakata H., Kasai T., Hashimoto H., Kodate M., Osaki T., and Yasumoto K. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology, 220(3):803–809, 2001.
[23] Cohen J. G., Reymond E., Lederlin M., Medici M., Lantuejoul S., Laurent F., Arbib F., Jankowski A., Moreau-Gaudry A., and Ferretti G. R. Differentiating pre-and minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in caucasian patients. European Journal of Radiology, 84(4):738–744, 2015.
[24] Lee J. H., Park C. M., Lee S. M., Kim H., McAdams H. P., and Goo J. M. Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: their natural course and predictors of interval growth. European Radiology, 26(6):1529–1537, 2016.
[25] MacMahon H., Naidich D. P., Goo J. M., Lee K. S., Leung A. N., Mayo J. R., Mehta A. C., Ohno Y., Powell C. A., Prokop M., et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology, 284(1):228–243, 2017.
[26] Oh J.-Y., Kwon S.-Y., Yoon H.-I., Lee S. M., Yim J.-J., Lee J.-H., Yoo C.-G., Kim Y. W., Han S. K., Shim Y.-S., et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer, 55(1):67–73, 2007.
[27] Felix L., Serra-Tosio G., Lantuejoul S., Timsit J.-F., Moro-Sibilot D., Brambilla C., and Ferretti G. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.
European Journal of Radiology, 77(3):410–416, 2011.
[28] Lee S. M., Park C. M., Goo J. M., Lee C. H., Lee H. J., Kim K. G., Kang M.-J., and Lee I. S. Transient part-solid nodules detected at screening thin-section CT for lung cancer: Comparison with persistent part-solid nodules 1. Radiology, 255(1):242–251, 2010.
[29] Naidich D. P., Bankier A. A., MacMahon H., Schaefer-Prokop C. M., Pistolesi M., Goo J. M., Macchiarini P., Crapo J. D., Herold C. J., Austin J. H., et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology, 266(1):304– 317, 2013.
[30] American College of Radiology. Lung CT Screening Reporting and Data System (Lung-RADS). http:// www.acr.org/Quality-Safety/Resources/LungRADS.
[31] LeCun Y., Bengio Y., and Hinton G. Deep learning. Nature, 521(7553):436–444, 2015.
[32] Swensen S. J., Silverstein M. D., Ilstrup D. M., Schleck C. D., and Edell E. S. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Archives of Internal Medicine, 157(8):849–855, 1997.
[33] Gould M. K., Ananth L., and Barnett P. G. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest, 131(2):383–388, 2007.
[34] Herder G. J., van Tinteren H., Golding R. P., Kostense P. J., Comans E. F., Smit E. F., and Hoekstra O. S. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18f-fluorodeoxyglucose positron emission tomography. Chest, 128(4):2490–2496, 2005.
[35] Lee S. M., Park C. M., Goo J. M., Lee H.-J., Wi J. Y., and Kang C. H. Invasive pulmonary adenocarcino- mas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology, 268(1):265–273, 2013.
[36] Lim H.-j., Ahn S., Lee K. S., Han J., Shim Y. M., Woo S., Kim J.-H., Yie M., Lee H. Y., and Chin A. Y. Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopatholog- ic comparisons and prognostic implications. Chest, 144(4):1291–1299, 2013.
[37] Ridge C. A., Yildirim A., Boiselle P. M., Franquet T., Schaefer-Prokop C. M., Tack D., Gevenois P. A., and Bankier A. A. Differentiating between subsolid and solid pulmonary nodules at CT: inter-and intraobserver agreement between experienced thoracic radiologists. Radiology, 278 (3):888–896, 2015.
[38] Callister M. E. and Baldwin D. R. How should pulmonary nodules be optimally investigated and managed? Lung Cancer, 91:48–55, 2016.
[39] Kim H. Y., Shim Y. M., Lee K. S., Han J., Yi C. A., and Kim Y. K. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology, 245(1):267– 275, 2007. [40] Yang P. S., Lee K. S., Han J., Kim E. A., Kim T. S., and Choo I. W. Focal organizing pneumonia: CT and
pathologic findings. Journal of Korean Medical Science, 16(5):573, 2001.
[41] Park C. M., Goo J. M., Lee H. J., Lee C. H., Chun E. J., and Im J.-G. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics, 27(2):391–408, 2007.
[42] Lee S. H., Lee S. M., Goo J. M., Kim K.-G., Kim Y. J., and Park C. M. Usefulness of texture analysis in differentiating transient from persistent part-solid nodules (psns): a retrospective study. PloS One, 9(1):e85167, 2014.
[43] Team N. L. S. T. R., Aberle D., Berg C., Black W., Church T., Fagerstrom R., Galen B., Gareen I., Gatsonis C., Goldin J., Gohagan J., Hillman B., Jaffe C., Kramer B., Lynch D., Marcus P., Schnall M., Sullivan D., Sullivan D., and Zylak C. The National Lung Screening Trial: overview and study design. Radiology, 258(1):243–253, 2011.
[44] Goo J. M., Park C. M., and Lee H. J. Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. American Journal of Roentgenology, 196(3):533–543, 2011. [45] Vazquez M., Carter D., Brambilla E., Gazdar A., Noguchi M., Travis W. D., Huang Y., Zhang L., Yip R.,
Yankelevitz D. F., et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer, 64(2):148–154, 2009. [46] Lee H. J., Goo J. M., Lee C. H., Park C. M., Kim K. G., Park E.-A., and Lee H. Y. Predictive CT findings of
malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance. European Radiology, 19(3):552–560, 2009.
[47] van Riel S. J., Sánchez C. I., Bankier A. A., Naidich D. P., Verschakelen J., Scholten E. T., de Jong P. A., Jacobs C., van Rikxoort E., Peters-Bax L., et al. Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management. Radiology, 277(3):863–871, 2015.
[48] Manos D., Seely J. M., Taylor J., Borgaonkar J., Roberts H. C., and Mayo J. R. The Lung Reporting and Data System (LU-RADS): a proposal for computed tomography screening. Canadian Association of
Radiologists Journal, 65(2):121–134, 2014.
[49] Xu D. M., van Klaveren R. J., de Bock G. H., Leusveld A. L., Dorrius M. D., Zhao Y., Wang Y., de Koning H. J., Scholten E. T., Verschakelen J., et al. Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules. European Journal of Radiology, 70(3):492–498, 2009.
[50] Winer-Muram H. T. The solitary pulmonary nodule. Radiology, 239(1):34–49, 2006.
[51] Oken M. M., Hocking W. G., Kvale P. A., Andriole G. L., Buys S. S., Church T. R., Crawford E. D., Fouad M. N., Isaacs C., Reding D. J., et al. Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA, 306(17): 1865–1873, 2011. [52] Hawkins S., Wang H., Liu Y., Garcia A., Stringfield O., Krewer H., Li Q., Cherezov D., Gatenby R. A.,
Balagurunathan Y., et al. Predicting malignant nodules from screening CT scans. Journal of
Thoracic Oncology, 11(12):2120–2128, 2016.
[53] Way T. W., Sahiner B., Chan H.-P., Hadjiiski L., Cascade P. N., Chughtai A., Bogot N., and Kazerooni E. Computer-aided diagnosis of pulmonary nodules on CT scans: Improvement of classification performance with nodule surface features. Medical Physics, 36(7):3086–3098, 2009.
[54] Han F., Wang H., Zhang G., Han H., Song B., Li L., Moore W., Lu H., Zhao H., and Liang Z. Texture feature analysis for computer-aided diagnosis on pulmonary nodules. Journal of Digital Imaging, 28(1):99–115, 2015.
[55] Godoy M. C. and Naidich D. P. Overview and strategic management of subsolid pulmonary nodules.
Journal of Thoracic Imaging, 27(4):240–248, 2012.
[56] Honda T., Kondo T., Murakami S., Saito H., Oshita F., Ito H., Tsuboi M., Nakayama H., Yokose T., Kameda Y., et al. Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification. Clinical Radiology, 68(1):e21–e26, 2013.
[57] Scholten E. T., de Jong P. A., de Hoop B., van Klaveren R., Van Amelsvoort-Van De Vorst S., Oudkerk M., Vliegenthart R., de Koning H. J., van der Aalst C. M., Vernhout R. M., et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?
European Respiratory Journal, 45(3):765–773, 2015.
[58] Gulati C. M., Schreiner A. M., Libby D. M., Port J. L., Altorki N. K., and Gelbman B. D. Outcomes of unresected ground-glass nodules with cytology suspicious for adenocarcinoma. Journal of
Thoracic Oncology, 9(5):685–691, 2014.
[59] Yankelevitz D. F., Yip R., Smith J. P., Liang M., Liu Y., Xu D. M., Salvatore M. M., Wolf A. S., Flores R. M., Henschke C. I., et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology, 277(2):555–564, 2015.
[60] Godoy M. C., Sabloff B., and Naidich D. P. Subsolid pulmonary nodules: imaging evaluation and strategic management. Current Opinion in Pulmonary Medicine, 18(4):304–312, 2012.
[61] Nakata M., Saeki H., Takata I., Segawa Y., Mogami H., Mandai K., and Eguchi K. Focal groundglass opacity detected by low-dose helical CT. Chest, 121(5):1464–1467, 2002.
[62] Kakinuma R., Noguchi M., Ashizawa K., Kuriyama K., Maeshima A. M., Koizumi N., Kondo T., Matsuguma H., Nitta N., Ohmatsu H., et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. Journal of Thoracic Oncology, 11(7):1012–1028, 2016.
[63] Hasegawa M., Sone S., Takashima S., Li F., Yang Z., Maruyama Y., and Watanabe T. Growth rate of small lung cancers detected on mass CT screening. British Journal of Radiology, 73(876): 1252–1259, 2000.
[64] Kobayashi Y. and Mitsudomi T. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected? Translational Lung Cancer Research, 2 (5):354, 2013.
[65] Baldwin D. R. and Callister M. E. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax, 70(8):794–798, 2015.
[66] Pinsky P., Gierada D., Black W., Munden R., Nath H., Aberle D., and E K. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Annals of Internal Medicine, 162(7):485–491, 2015.
[67] Lung Cancer Screening. National Comprehensive Cancer Network Guidelines, Version 1.2016, 2016. [68] Hwang I.-P., Park C. M., Park S. J., Lee S. M., McAdams H. P., Jeon Y. K., and Goo J. M. Persistent pure
ground-glass nodules larger than 5 mm: differentiation of invasive pulmonary adenocarcinomas from preinvasive lesions or minimally invasive adenocarcinomas using texture analysis.
Investigative Radiology, 50(11):798–804, 2015.
[69] Zhang Y., Shen Y., Qiang J. W., Ye J. D., Zhang J., and Zhao R. Y. HRCT features distinguishing pre-invasive from invasive pulmonary adenocarcinomas appearing as ground-glass nodules.
European Radiology, 26(9):2921–2928, 2016.
[70] Travis W. D., Brambilla E., Noguchi M., Nicholson A. G., Geisinger K. R., Yatabe Y., Beer D. G., Powell C. A., Riely G. J., Van Schil P. E., et al. International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society international multi- disciplinary classification of lung adenocarcinoma. Journal of Thoracic Oncology, 6(2):244–285, 2011.
[71] Liang J., Xu X., Xu H., Yuan M., Zhang W., Shi Z., and Yu T. Using the CT features to differentiate invasive pulmonary adenocarcinoma from pre-invasive lesion appearing as pure or mixed ground-glass nodules. British Journal of Radiology, 88(1053):20140811, 2015.
[72] Mario S., Nicola S., Carmelinda M., Giulio N., Alfonso M., Maurizio Z., Cristina R., and Ugo P. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. Journal of Thoracic
Oncology, 7(10):1541–1546, 2012.
[73] Chang B., Hwang J. H., Choi Y.-H., Chung M. P., Kim H., Kwon O. J., Lee H. Y., Lee K. S., Shim Y. M., Han J., et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
Chest, 143(1):172–178, 2013.
[74] White C. S., Dharaiya E., Campbell E., and Boroczky L. The Vancouver lung cancer risk prediction model: Assessment by using a subset of the National Lung Screening Trial cohort. Radiology, 283(1):264–272, 2016.
[75] Wille M. M. W., van Riel S. J., Saghir Z., Dirksen A., Pedersen J. H., Jacobs C., Thomsen L. H., Scholten E. T., Skovgaard L. T., and van Ginneken B. Predictive accuracy of the PanCan lung cancer risk prediction model-external validation based on CT from the Danish Lung Cancer Screening Trial.
European Radiology, 25(10):3093–3099, 2015.
[76] Gallardo-Estrella L., Lynch D. A., Prokop M., Stinson D., Zach J., Judy P. F., van Ginneken B., and van Rikxoort E. M. Normalizing computed tomography data reconstructed with different filter kernels: effect on emphysema quantification. European Radiology, 26(2):478–486, 2016.
[77] Hanley J. A. and McNeil B. J. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology, 143(1):29–36, 1982.
[78] Steyerberg E. W. Clinical prediction models: a practical approach to development, validation, and
updating. Springer Science & Business Media, 2008.
[79] Steyerberg E. W., Harrell F. E., Borsboom G. J., Eijkemans M., Vergouwe Y., and Habbema J. D. F. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. Journal of Clinical Epidemiology, 54(8):774–781, 2001.
[80] Zhao H., Marshall H. M., Yang I. A., Bowman R. V., Ayres J., Crossin J., Lau M., Slaughter R. E., Redmond S., Passmore L., et al. Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model. British Journal of Radiology, 89(1060):20160016, 2016.
[81] de Koning H. J., Meza R., Plevritis S. K., Ten Haaf K., Munshi V. N., Jeon J., Erdogan S. A., Kong C. Y., Han S. S., van Rosmalen J., et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the us preventive services task force. Annals of
Internal Medicine, 160(5):311–320, 2014.
[82] Messay T., Hardie R. C., and Rogers S. K. A new computationally efficient CAD system for pulmonary nodule detection in CT imagery. Medical Image Analysis, 14(3):390–406, 2010.
[83] Jacobs C., van Rikxoort E. M., Twellmann T., Scholten E. T., de Jong P. A., Kuhnigk J.-M., Oud-kerk M., de Koning H. J., Prokop M., Schaefer-Prokop C., et al. Automatic detection of subsolid pulmonary nodules in thoracic computed tomography images. Medical Image Analysis, 18(2): 374–384, 2014. [84] Setio A. A., Jacobs C., Gelderblom J., and Ginneken B. Automatic detection of large pulmonary solid
nodules in thoracic CT images. Medical Physics, 42(10):5642–5653, 2015.
[85] Setio A. A. A., Ciompi F., Litjens G., Gerke P., Jacobs C., van Riel S. J., Wille M. M. W., Naqibullah M., Sánchez C. I., and van Ginneken B. Pulmonary nodule detection in CT images: false positive